PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
Clinical trial NCT01659970 · COMPLETED
Trial details
- NCT number
- NCT01659970
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-04-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.